MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TLSI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TriSalus Life Sciences (TLSI) Ownership - Who owns TriSalus Life Sciences?

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
6272 W. 91st Avenue
Phone
N/A
Employees
N/A
Web
https://trisaluslifesci.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
257.95M
P/E Ratio
0.08
Total Cash
56.55M
Projected Growth
N/A
Total Debt
34.49M
Revenue
44.88M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.92
Total Debt/Equity
N/A
Revenue/Share
1.02 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TLSI
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for TLSI
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Details
Industry
N/A
Address
6272 W. 91st Avenue
Phone
N/A
Employees
N/A
Web
https://trisaluslifesci.com